Pacific Biosciences of California, Inc. (PACB)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Integrated Platform for Genetic Analysis	160.01M	154.01M	200.52M	128.30M	130.51M
Total	160.01M	154.01M	200.52M	128.30M	130.51M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Americas	-	-	-	-	64.52M
Europe, Middle East and Africa	44.05M	34.59M	40.66M	22.60M	30.27M
Asia Pacific	43.16M	40.71M	54.45M	36.15M	35.72M
United States of America	69.70M	75.30M	100.50M	66.80M	-
Americas (excl. United States)	3.10M	3.41M	4.91M	2.76M	-
Total	160.01M	154.01M	200.52M	128.30M	130.51M

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error